99m Tc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases

Anticancer Research

Volumn 17, Issue 3 B, 1997, Pages 1615-1618

  Limouris, Georgios S ^a   Voliotopoulos, Vassilios ^a   Stavraka, Anastasia ^a   Vlahos, Lambros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bone metastases; Tc 99m antigranulocyte; Tc 99m MDP

Indexed keywords

ANTIGRANULOCYTE TECHNETIUM 99M; BISPHOSPHONIC ACID DERIVATIVE; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW SCINTISCANNING; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOTHERAPY; BONE MARROW; BONE TUMOR; BREAST TUMOR; FOLLOW UP; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; RADIOIMMUNOASSAY; REPRODUCIBILITY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; BONE MARROW; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M MEDRONATE;

EID: 0030610274     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Harris JR, Lippman ME, Veronesi V et al: Breast cancer. N Engl J Med 327: 319-328, 1992.
2. American Cancer Society: Mammography guidelines. Cancer 33: 255, 1983.
3. Jackson VP, Hendrick RE, Kerg SA, et al: Imaging of the radiographically dense breast. Radiology 198: 297-301, 1993.
4. Parker SH, Lovin JD, Jobe WF, et al: Stereotactic breast biopsy with a biopsy gun. Radiology 176: 741-747, 1990.
5. Bekerman C, Hoffer PB, Bitran JD, et al: The role of gallium-67 in the clinical evaluation of cancer. Sem Nucl Med 14: 296-323, 1984.
6. 201TI chloride. Radiology 129: 497-500, 1978.
7. 201TI uptake in tumours. Eur J Nucl Med 15: 376-379, 1989.
8. Schweil AM, Mckillop JH, Milroy R et al: Thallium scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 11: 263-269, 1990.
9. Waxman AD, Ramenna L, Memsic LD et al: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34: 18-23, 1993.
10. 99mTc- methoxyisobutylisonitrile (MIBI) in humans. Eur J Nucl Med 15: 597-600, 1989.
11. Kao CH, Wang SJ, Lin TJ: The use of technetium-99m methosyisobutyl isonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994.
12. Villanueva-Meyer J, Leonard Jr MH, Briscoe E et al: Mammoscintigraphy with technetium-99m-Sestamibi in suspected breast cancer. J Nucl Med 37: 926-930, 1996.
13. Khalkhali I, Mena I, Diggles L' Review of imaging techniques for the diagnosis of breast cancer. A new role of prone scintimammography using technetium-99m-sestamibi. Eur J Nucl Med 21: 357-362, 1994.
14. Khalkhali I, Mena I, Jouanne E et al: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 178: 491 -497, 1994.
15. Highley B, Smith FW, Smith et al: Technetium 99m-1,2 bis (bis(2-ethoxy-ethyl) phosphino) ethane: tumour biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 34: 30-38, 1993.
16. Kopans DB- The positive predictive value of mammography.A J R 158: 521-526, 1992.
17. Piccolo S, Lesteria S, Mainolfi C et al: Technetium 99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 36: 718-724, 1995.
18. van Eijck CHJ7 Krennig Ep, Bootsma A et al: Somatostatin-receptor scintigraphy in primary breast cancer. Lancet 343: 640-643, 1994.
19. Richman SD, Ingle JN, Levenson SM et al: Usefulness of gallium scintigraphy in primary and metastatic breast carcinoma. J Nucl Med 16: 996-1001, 1975.
20. Palmedo H, Schonburg A, Grunwald F et al: Technetium-99m MIBI scintimammography for suspicious breast lesions. J Nucl Med 37: 626-630, 1996.
21. Niewey O, Kim E, Wang WH et al: Positron emission tomography with fluorine-18deoxyglucose in the detection and staging of breast cancer. Cancer 71: 3920-3925, 1993.
22. 99mTc-Tetrofosmin. Clin Nucl Med 20: 703-705, 1995.
23. 99mTc-Tetrofosmin uptake in breast tumours (Abstract). J Nucl Med 36: suppl 5 .339P, 1995.
24. Schillacci O, Scopinaro F, Danieli R et al: Technetium-99m tetrofosmin scan in breast lesions: Preliminary results. (Abstract). E J Nucl Med 22: 613P, 1995.